Keloid is a kind of unique human fibroproliferative dermal disease, and there are still no optimal treatment methods for it. In the present study, a thermosensitive hydroxybutyl chitosan (HBC) hydrogel as a co-delivery matrix for 5-fluorouracil (5-FU) and dexamethasone sodium phosphate (DEXSP) in keloid treatment was developed. The gelation temperature of the HBC hydrogel was observed to be 25.7 °C by rheology analysis. The HBC hydrogel showed sustained drug release capacity (5-FU, 89.3 ± 3.4%; DEXSP, 95.6 ± 3.9%) for drug delivery. The HBC hydrogel was shown to be cytocompatible, while the dual drug-loaded HBC hydrogel could suppress the proliferation of keloid fibroblasts (KFs). The keloid biopsies treated with the dual drug-loaded hydrogel could be inhibited through the efficient suppression of VEGF expression within 7 days. The results suggested that the HBC hydrogel could be applied as a potential co-delivery matrix for drugs in the keloid therapy field.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c6tb00378hDOI Listing

Publication Analysis

Top Keywords

hbc hydrogel
24
co-delivery matrix
12
thermosensitive hydroxybutyl
8
hydroxybutyl chitosan
8
hydrogel
8
potential co-delivery
8
matrix drugs
8
drugs keloid
8
dual drug-loaded
8
keloid
6

Similar Publications

Full bio-degradation of super absorbent hydrogels (SAHs), which possess excellent water uptake capacity, is still challenging. Based on Flory theory, this paper first analyzes that the high swelling property and gel strength of SHAs are attributed to the length of effective chain of crosslinker. Firstly, a series of hyperbranched crosslinker (HBC) with different molecular weights were designed and synthesized by anionic polymerization and sodium lignosulfonate (SL), which owns a hydrophilic network and remarkable biodegradation properties, was selected as a monomer.

View Article and Find Full Text PDF
Article Synopsis
  • - Endoscopic submucosal dissection (ESD) is effective for treating polyps and early GI cancers but requires skilled operators; injecting materials into the submucosa can improve outcomes by creating a cushion.
  • - Current submucosal injection materials often spread quickly and do not provide long-lasting support, highlighting the need for a more durable alternative.
  • - Researchers developed a new material called succinylated hydroxybutyl chitosan (HBC-SA), which has better lifting properties and biocompatibility than traditional materials, making it a promising option for use during ESD.
View Article and Find Full Text PDF

Revolutionizing pressure ulcer regeneration: Unleashing the potential of extracellular matrix-derived temperature-sensitive injectable antioxidant hydrogel for superior stem cell therapy.

Biomaterials

March 2025

School of Biomedical Engineering, Shenzhen Campus of Sun Yat-Sen University, No. 66, Gongchang Road, Guangming District, Shenzhen, Guangdong, 518107, People's Republic of China. Electronic address:

Article Synopsis
  • * A new thermosensitive injectable hydrogel (adEHG), made from gallic acid-modified hydroxybutyl chitosan and soluble extracellular matrix, enhances stem cell viability and function by mimicking their natural environment while protecting against oxidative stress.
  • * The adEHG hydrogel not only promotes important processes like angiogenesis and collagen deposition but also aids in wound healing by encouraging beneficial macrophage behavior, improving the prospects for using stem cell therapies in treating pressure ulcers.
View Article and Find Full Text PDF

Crocin-1 laden thermosensitive chitosan-based hydrogel with smart anti-inflammatory performance for severe full-thickness burn wound therapeutics.

Carbohydr Polym

December 2024

Laboratory of Biochemistry and Biomedical Materials, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, PR China. Electronic address:

Burns are the fourth most common type of civilian trauma worldwide, and the management of severe irregular scald wounds remains a significant challenge. Herein, crocin-1 laden hydroxybutyl chitosan (CRO-HBC) thermosensitive hydrogel with smart anti-inflammatory performance was developed for accelerating full-thickness burn healing. The injectable and shape adaptability of the CRO-HBC gel make it a promising candidate for effectively filling scald wounds with irregular shapes, while simultaneously providing protection against external pathogens.

View Article and Find Full Text PDF

Background: Third molar (M3) extraction is a common surgery in oral and maxillofacial surgery, and composite wound dressings such as hydroxybutyl chitosan (HBC) may improve postoperative sequala following M3 removal.

Purpose: The study purpose was to measure and compare differences in pain, swelling, trismus, wound healing, and quality of life (QOL) between the HBC and the control sides in patients undergoing M3 removal.

Study Design, Setting, Sample: This study is a double-blind, split-mouth, randomized clinical trial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!